Introduction to sacral neuromodulation therapy for urinary bladder dysfunction using an InterStim system.

Area of Science:

• Urology
• Neurology

Background:

• Refractory overactive bladder and idiopathic non-obstructive urinary retention significantly impact patient quality of life.
• Conservative treatments often fail or are poorly tolerated by affected patients.
• Sacral neuromodulation is an internationally endorsed therapy for these conditions.

Purpose of the Study:

• To evaluate the efficacy and patient satisfaction of sacral neuromodulation for refractory overactive bladder and urinary retention.
• To highlight the benefits of the Medtronic InterStim System in managing these urological conditions.

Main Methods:

• Utilizes sacral neuromodulation, specifically the Medtronic InterStim System.
• CE mark approval obtained in 1995 for bladder indications.
• Over 300,000 patients treated worldwide.

Main Results:

• Patient satisfaction rates range from 61-90%.
• Demonstrates a safe and effective intervention for overactive bladder and urinary retention.
• Positively impacts the management of these prevalent conditions.

Conclusions:

• Sacral neuromodulation is a highly effective treatment option for patients with refractory overactive bladder and urinary retention.
• The therapy provides significant relief and improves patient outcomes.
• Addresses the distressing symptoms and economic burden associated with overactive bladder.